SLC6A3 and Parkinson disease: Intriguingly, LRRK2 PD patients display similar alterations in DAT and SERT, compared to idiopathic PD, while unaffected LRRK2 mutation carriers have an increase in SERT binding in specific brain regions, such as striatum and hypothalamus [57].